Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 99, 103767
Abstract
No abstract availableKeywords
Funding Information
- Minia University
- National Cancer Institute
- Shanghai Key Laboratory of New Drug Design
This publication has 85 references indexed in Scilit:
- Synthesis and Evaluation of 1,5-Disubstituted Tetrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative and Antitumor ActivityJournal of Medicinal Chemistry, 2011
- Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazolesEuropean Journal of Medicinal Chemistry, 2010
- Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole–pyrrolobenzodiazepine conjugatesBioorganic & Medicinal Chemistry, 2010
- Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin AnaloguesJournal of Medicinal Chemistry, 2010
- Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studiesBioorganic & Medicinal Chemistry, 2010
- Design, Synthesis, and Biological Evaluations of 2,5-Diaryl-2,3-dihydro-1,3,4-oxadiazoline Analogs of Combretastatin-A4Journal of Medicinal Chemistry, 2009
- In Vitro Metabolism Study of Combretastatin A-4 in Rat and Human Liver MicrosomesDrug Metabolism and Disposition, 2007
- Synthesis and cytotoxic activities of 4,5-diarylisoxazolesBioorganic & Medicinal Chemistry Letters, 2007
- DocetaxelDrugs, 2005
- Podophyllotoxin derivatives: drug discovery and developmentDrug Discovery Today, 1996